Modeling neurocognitive and neurobiological recovery in addiction by Meyerhoff, Dieter & Durazzo, Timothy C
UCSF
UC San Francisco Previously Published Works
Title
Modeling neurocognitive and neurobiological recovery in addiction
Permalink
https://escholarship.org/uc/item/3m0750tb
ISBN
9780128152980
Authors
Meyerhoff, Dieter
Durazzo, Timothy C
Publication Date
2019-09-26
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
UN
CO
RR
EC
TE
D
PR
OO
FModeling neurocognitive and
neurobiological recovery in addiction
Dieter J. Meyerhoff1 and Timothy C. Durazzo2
1University of California San Francisco and San Francisco VA Medical Center, 2Stanford University and Palo Alto VA Medical Center
MODELING NEUROCOGNITIVE AND NEUROBIOLOGICAL RECOVERY IN
ADDICTION
Neurocognitive dysfunction associated with alcohol and substance use disorders (SUDs) has been well-established
and is the topic of most chapters in this book. However, neurocognitive changes occurring during abstinence from
alcohol and substances have been less frequently described. This chapter first summarizes the main neurocognitive and
neurobiological abnormalities associated with alcohol and SUDs, before reviewing more extensively the neurocognitive
and neurobiological changes that occur with abstinence from alcohol and other substances. As a recent review focused on
findings from functional magnetic resonance imaging (fMRI) and positron emission tomography studies during abstinence
from alcohol (Charlet et al., 2018), the neurobiological descriptions here focus on brain morphological and spectroscopic
MR studies of individuals with alcohol and/or SUDs. While the neurocognitive and neurobiological abnormalities
associated with addiction increase mortality and morbidity for the afflicted individual and the society, there is also clear
evidence of adaptive and variable recovery from these abnormalities. A better understanding of the specific changes
associated with abstinence, their trajectories over time, and of their potential mechanisms will inform more efficacious
interventions for alcohol and SUDs in future. Additionally, a better understanding of the course of neurobiological changes
associated with abstinence can ultimately serve as powerful psychoeducational information for those considering and
seeking treatment for alcohol and SUDs.
NEUROCOGNITIVE DEFICITS IN ADDICTION
Alcohol and SUDs in general (cocaine, methamphetamine, cannabis, or tobacco) are associated with dysfunction, primarily
in the domains of learning/memory, working memory, and other executive-based skills, including cognitive/inhibitory
control (extensively reviewed in previous chapters). Persons with alcohol use disorder (AUD) have been studied most,
with the nature and level of impairment showing considerable variability (for recent reviews, see Stavro et al., 2013;
Bernardin et al., 2014; Oscar-Berman et al., 2014; Le Berre, Fama et al., 2017). Approximately 55% of AUD manifest
clinically significant neurocognitive deficits after acute detoxification (i.e., >1.5 standard deviations below the level
in healthy controls), but some degree of recovery from these deficits is apparent with short-term (i.e., ≤1 month),
intermediate-term (i.e., 1–12 months), and long-term (i.e., >1 year) abstinence from alcohol (Rourke and Grant, 2009;
Durazzo et al., 2014b). Some dysfunction has been reported to persist into long-term abstinence from alcohol, particularly
in the domains of executive and visuospatial skills, learning and memory, and postural stability (Durazzo and Meyerhoff,
2007; Rourke and Grant, 2009; Stavro et al., 2013; Le Berre, Fama et al., 2017). The degree of cognitive dysfunction
and the rate of recovery during abstinence appear to be influenced by many factors such as age, sex, family history of
AUD, treatment history, pretreatment alcohol consumption level, number of detoxifications, nutritional status, comorbid
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psychiatric and biomedical conditions, and comorbid SUD (Durazzo and Meyerhoff, 2007; Oscar-Berman and
Marinkovic, 2007; Rourke and Grant, 2009; Schulte et al., 2014).
Most treatment-seeking substance users today concurrently and/or simultaneously consume more than one illicit/licit
compound, so-called polysubstance users (PSU) (Hasin and Grant, 2015). Among PSU, comorbid tobacco use disorder
is most prevalent in AUD (Durazzo and Meyerhoff, 2007; Weinberger et al., 2016), and chronic cigarette smoking itself
is associated with significant neurocognitive deficiencies (e.g., visuospatial memory, motor impulsivity) in both AUD
and non-AUD cohorts (e.g., Brody, 2006; Glass et al., 2005; Durazzo et al., 2006b; Gazdzinski et al., 2006; Durazzo
and Meyerhoff, 2007; Almeida et al., 2008; Durazzo et al., 2010a; Durazzo et al., 2011; Durazzo et al., 2012; Morales
et al., 2012; Pennington et al., 2013; Durazzo et al., 2014b; Durazzo et al., 2015a,b). Smoking AUD performed worse
than their nonsmoking counterparts on domains of auditory verbal learning and memory, processing speed, cognitive
efficiency, and working memory during the first month of abstinence from alcohol (Durazzo et al., 2006b; Pennington et
al., 2013). Smoking AUD also demonstrated poorer neurocognition with increasing age than never-smoking AUD, and the
performance of former-smoking AUD on several domains was intermediate to that of never-smoking and actively smoking
AUD (Durazzo et al., 2013b; Pennington et al., 2013).
Particularly common among PSU is the simultaneous and/or concurrent abuse of alcohol, tobacco, and
psychostimulants (Moss et al., 2015). Therefore, in many published research reports on the neurobiological and
neurocognitive consequences of AUD, many individuals were also likely nicotine-dependent, and in studies of cocaine use
disorder, participants were also likely heavy drinkers. This was both likely and most apparent in literature before about
2010, when polysubstance abuse had not been attended to more widely in substance abuse research, and other substance
use was largely treated as a nuisance variable. More recently, poorer health outcomes and greater treatment resistance
have been reported for PSU compared to monosubstance users (Walitzer et al., 2015; Weinberger et al., 2017). Despite
its prevalence, however, few studies have directly examined the neuropsychological or neurobiological consequences of
polysubstance abuse. In early studies, cocaine-dependent individuals with and without AUD showed cognitive deficits at
3 months of abstinence (Di Sclafani, Bloomer et al., 1998), and decision-making was still impaired in similar individuals
abstinent for 8 months (Verdejo-Garcia et al., 2007). Even after several years of abstinence, psychostimulant-related
deficits of episodic memory, planning, and cognitive flexibility were persistent in PSU (Fernandez-Serrano et al., 2011).
These relatively persistent cognitive deficits were associated with the amount of cocaine and cannabis consumed
(Fernandez-Serrano et al., 2010; Schmidt et al., 2017) as well as with relapse risk (Verdejo-Garcia et al., 2007;
Verdejo-Garcia et al., 2012). Cognitive efficiency, processing speed, and visuospatial learning were less impaired in
1-month-abstinent PSU who continued to abstain versus those who subsequently relapsed between 1 and 4 months
of abstinence (Schmidt et al., 2017); similarly, 1-month-abstinent AUD with the lowest processing speed showed a
significantly increased risk for relapse following treatment (Durazzo et al., 2008a,b). In comparisons to 1-month-abstinent
AUD, 1-month-abstinent PSU performed worse on measures of auditory verbal memory and learning and general
intelligence (Schmidt et al., 2017), suggesting a diminished capacity (compared to ALC) of learning, memorizing, and
integrating new skills presented in clinical treatment settings. In addition, PSU exhibited worse decision-making and
higher self-reported impulsivity than AUD, potentially placing them at a greater relapse risk during early recovery. Finally,
PSU between the ages of 25 and 70 years showed greater age-related declines in processing speed, general intelligence,
cognitive efficiency, and global intelligence than controls, indicating the detrimental cumulative effects of polysubstance
use on neurocognition (Schmidt et al., 2017).
As described, the degree and nature of neurocognitive deficits varies considerably among substance-using groups
investigated, critically related to the combination of both illicit and licit substances abused and their use histories.
However, it is noteworthy that even mild neurocognitive deficits can impact quality of life and relapse risk (Goldstein
et al., 2004; Bates et al., 2013). Impaired neurocognition and inhibition may adversely affect maintenance of abstinence
during treatment and long-term treatment efficacy (Aharonovich et al., 2006; Passetti et al., 2008; Streeter et al., 2008; de
Wit, 2009; Bates et al., 2013; Stevens et al., 2014; Rupp et al., 2016); specifically, neurocognitive deficits can interfere
with treatment efficacy by reducing the individual's ability to encode, process, recall, integrate, and apply program
information during and following treatment (Durazzo et al., 2008a,b; Dominguez-Salas et al., 2016; Rezapour et al., 2016).
As such, assessment of cognitive abilities during treatment may improve treatment outcomes by providing clinicians an
understanding of the individual's capabilities during treatment and inform appropriate posttreatment follow-up care (Bates
et al., 2013).
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Neurocognitive changes during abstinence
Studies of longitudinal neurocognitive changes during abstinence from alcohol and other substances are far less common
than cross-sectional studies (e.g., Fernandez-Serrano et al., 2011). Most longitudinal studies assessed neurocognition
several weeks after detoxification and then 6–12 months later; they demonstrated several neurocognitive functions improve
at least partially during sustained abstinence, whereas some cognitive dysfunction persists for years after detoxification
(for recent reviews, see Bernardin et al., 2014; Oscar-Berman et al., 2014; Le Berre et al., 2017). Psychological changes
in AUD during a residential rehabilitation program have recently been documented and include significant decreases in
anxiety, depression, and psychological distress within about 1 month of detoxification in those with substance-induced
mood disorders (Giorgi et al., 2015). In studies on the effects of comorbid tobacco use on neurocognitive recovery in AUD
(Durazzo et al. 2006a, 2007b; Durazzo et al., 2010a; Pennington et al., 2013), we found that smoking was associated with
significantly diminished improvement of visuospatial learning and processing speed within the first year of abstinence
from alcohol (Pennington et al., 2013; Durazzo et al., 2014b).
We analyzed neurocognition across three different time points during abstinence from alcohol (1 week, 1 month, and
8 months) and as a function of smoking status (never-smoking, former-smoking, and actively smoking AUD) (Durazzo et
al., 2014b). Over 8 months of abstinence, AUD as a group showed significant improvements of visuospatial learning and
memory, processing speed, and working memory, with less pronounced changes in executive functions, postural stability,
and auditory verbal learning and memory. Overall, the recovery rates were nonlinear over time, showing faster recovery
between 1 and 4 weeks than between 1 and 8 months of abstinence. Improvements in the foregoing domains in AUD
were driven by never-smoking AUD, where both former-smoking and actively smoking AUD showed significantly less
recovery than never-smoking AUD. Additionally, active smokers showed significantly less improvement with increasing
age than never-smoking AUD over 8 months on measures of processing speed and learning and memory. At 8 months of
abstinence, currently smoking AUD remained inferior to controls and never-smoking AUD on multiple measures, former
smokers performed worse than never-smoking AUD on several tests, but never-smoking AUD were not significantly
different from controls on any measure. Thus, in this AUD cohort over 8 months of abstinence from alcohol, smoking
status interacted with both abstinence duration and age to robustly moderate recovery on measures of auditory verbal and
visuospatial learning and memory, as well as processing speed. The above findings were adjusted for education, estimated
premorbid verbal intelligence, lifetime drinking severity, and medical, psychiatric, and substance misuse comorbidities.
Importantly, in actively smoking AUD, more lifetime years of tobacco use were related to poorer recovery of auditory
verbal memory over 8 months of abstinence (Durazzo et al., 2014b). For a discussion of smoking-related neurobiological
mechanisms potentially underlying the differential recovery observed in AUD subgroups, see Durazzo et al. (2010a) and
Durazzo et al. (2014a).
In studies of neurocognitive recovery during abstinence from substances, neurocognition was largely unchanged over
1 month of abstinence from methamphetamine (Simon et al., 2010), but improved somewhat over longer periods of
sustained abstinence (Iudicello et al., 2010). Attention, working memory, declarative memory, and executive functions
in cocaine users improved in those who decreased their cocaine use over a 1-year interval and normalized in those
who were abstinent for 1 year (Vonmoos et al., 2014). Decline of working memory over 1 year was associated with
increased cocaine use in these individuals and with younger age of onset of cocaine use. In abstinent PSU, cross-sectional
studies with different durations of abstinence did (Verdejo-Garcia et al., 2004; Fernandez-Serrano et al., 2011) or did not
(Medina et al., 2004) suggest recovery from neurocognitive dysfunction. The additive detrimental effects of concurrent
cocaine and alcohol dependence persisted over 1 month of abstinence (Bolla et al., 2000). However, over 6 months of
abstinence, individuals with comorbid alcohol and stimulant use disorders demonstrated improvements on measures of
immediate memory (Fein et al., 2002), and improvements in verbal short-term memory were also observed over 3–4
months of abstinence from substances (Block et al., 2002). Concurrent use of substances in those with AUD (i.e., PSU)
hampered neurocognitive recovery (Schulte et al., 2014), consistent with the detrimental effects of comorbid tobacco
use in AUD. Nevertheless, in treatment-seeking PSU who maintained abstinence (other than tobacco) for 3 months
after their baseline assessment at 1 month of sobriety (Schmidt et al., 2017), we observed significant improvements
in executive functions, cognitive efficiency and processing speed, working memory, and reductions in self-reported
impulsivity (Dominguez-Salas et al., 2016; Rezapour et al., 2016). These improvements likely aid in treatment adherence
and reduce relapse risk. Fine motor skills, learning, and memory, however, remained deficient after 4 months of abstinence,
especially in smoking PSU. During abstinence, self-reported impulsivity decreased in PSU, whereas performance on
a measure of decision-making/risk-taking did not improve, commensurate with findings for long-term abstinent AUD
(Fein et al., 2004) (but see Loeber et al., 2010). Thus, although some deficits appear to be more enduring (and may be
Modeling neurocognitive and neurobiological recovery in addiction
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potentially premorbid and serve as risk factors for development of an addictive disorder (Rezapour et al., 2016)), PSU
showed significant recovery across multiple neurocognitive domains over 3 months of sustained abstinence, despite
decades of substance abuse.
Taken together, significant neurocognitive improvements are generally observed beyond about 1 month of abstinence
in those with SUD, whereas abstinent individuals with AUD appear to show a more rapid recovery trajectory. However,
the research dedicated to studying the short-term and long-term neurocognitive recovery in AUD is considerably greater
than that in SUD, and more longitudinal research is required to more fully explicate the course of neurocognitive recovery
with abstinence in those with SUD. These neurocognitive recoveries during abstinence suggest that the deficits are largely
a consequence of chronic alcohol and/or substance use and the associated maladaptive lifestyle (i.e., poor diet/nutrition,
physical activity, sleep); some persistent deficits may be premorbid and may have contributed to initiation of alcohol
or substance abuse in the first place or are related to clinically significant comorbid conditions. The neurocognitive
changes during abstinence suggest parallel adaptive neuroplasticity, which may present a critical window of opportunity
for augmenting recovery in AUD and SUD with plasticity-based neurocognitive remediation, magnetic/electric stimulation
methods, or targeted pharmacology (Rabin et al., 2015; Klein, 2016; Rezapour et al., 2016), in particular during the initial
months of abstinence (Durazzo et al., 2014b). The corresponding neurocognitive improvements in these individuals (and
neurobiology, discussed next) will likely promote better treatment response—as demonstrated for AUD (Bates et al., 2013)
—and ultimately longer abstinence.
Neurobiological abnormalities in addiction
Underlying the neurocognitive deficits in AUD and SUD as well as their changes with abstinence from alcohol and/or
substances are neurobiological adaptations and their changes during abstinence. Here, we first review MR-based studies of
brain alterations in addiction, followed by review of serial MR studies performed to better understand the neuroadaptations
associated with recovery during abstinence. We focus on descriptions of MR structural and spectroscopic findings in
addiction, with the vast fMRI field not covered (but see Charlet et al., 2018).
Magnetic resonance (MR)–based neuroimaging studies of individuals with use disorders of alcohol, cocaine,
amphetamines, marijuana, or tobacco have revealed regional brain atrophy as correlates of neurocognitive dysfunction (for
reviews, see Goldstein and Volkow, 2011; Wang et al., 2015; Buhler and Mann, 2011; Sneider et al., 2013; Xiao et al.,
2015; Sullivan et al., 2018). Atrophy is observed throughout the brain with a prefrontal preference and is likely driven
by loss of, or damage to, neuronal cell bodies, dendrites (including dendritic spines, axons/teledendria/terminal endings
as demonstrated neuropathologically), and/or glial cells (Crews and Boettiger, 2009; Zahr et al., 2011). However, abused
substances may affect brain structures differentially, potentially related to the distribution of specific receptors (such as
cannabinoid or cholinergic receptors) throughout the brain and/or to the heterogeneity of substance use severities across the
different brain imaging studies published. In addition to variable and regionally varying cortical atrophy, psychostimulant
studies describe enlargement of subcortical structures: For example, methamphetamine users (Chang et al., 2007), heavy
cannabis users (Moreno-Alcázar et al., 2018; Nader and Sanchez, 2018), and cocaine-dependent individuals (Ersche et al.,
2011) (as well as their unaffected siblings (Ersche et al., 2013)) have all been shown to have enlarged striatal volumes.
Additionally, prescription opioid analgesics are associated with both decreases and increases of regional brain volumes
after only 1 month of opioid administration, with many of the changes persisting for 5 months after discontinuation
(Younger et al., 2011).
Consistent with the above reports on (ostensibly) monosubstance users, structural brain abnormalities have also been
described in PSU, who are the largest but most understudied SUD group. Greater years of polysubstance use were
related to lobar cortical and thalamic gray matter volume loss (Noyan et al., 2016). In comparison to AUD, PSU had
larger lobar white matter volumes in the absence of the widespread gray matter volume loss typically observed in AUD
with comparable lifetime drinking and smoking histories (Pennington et al., 2015). Furthermore, PSU exhibited distinct
relationships between regional brain volumes and processing speed, cognitive efficiency, working memory, and inhibitory
control, which were not observed in AUD or controls; this suggests potential alterations/compensations in neural circuits
of PSU that are classically associated with the above functional domains. Taken together, neuronal atrophy in PSU may
be countered by the adverse effects of reactive gliosis and neuroinflammation (as reflected in the subcortical volume
enlargements of psychostimulant users), possibly masking atrophy typically observed in AUD.
Other neuroimaging methods help assess functional alterations or neurobiological mechanisms underlying brain
structural alterations in addiction. They include functionally relevant low cerebral blood flow (Rogers et al., 1983;
Tunving et al., 1986; Volkow et al., 1988; Nicolas et al., 1993; Oishi et al., 1999; Ernst et al., 2000a,b; Gansler et al.,
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2000; Chang et al., 2002; Hwang et al., 2006; Heinz et al., 2009; Murray et al., 2018), altered brain glucose metabolism
(Volkow et al., 1993; Volkow et al., 1994; Volkow et al., 2001; Eldreth et al., 2004; Kim et al., 2005), and altered brain
metabolite levels measured by proton magnetic resonance spectroscopy (MRS). MRS studies revealed regional metabolic
abnormalities in those with alcohol and SUDs that are consistent with abnormal markers of neuronal integrity (as measured
by lower concentrations of N-acetylaspartate [NAA] or glutamate [Glu]), cellular bioenergetics (as indicated by lower
concentrations of creatine-containing metabolites, Cr), glial or cell membrane turnover/synthesis (as indicated by altered
levels of choline-containing metabolites, Cho), and glial content/gliosis or osmoregulation (as reflected in altered levels
of myo-inositol [mI]) (Meyerhoff et al., 1994; Fein et al., 1995; Meyerhoff et al., 1999; Ernst et al., 2000a,b; O'Neill et
al., 2001; Parks et al., 2002; Durazzo et al., 2004; Ke et al., 2004; Meyerhoff et al., 2004; Nordahl et al., 2005; Chang et
al., 2007; Hermann et al., 2007; Durazzo et al., 2008a,b; Durazzo et al., 2010b; Sailasuta et al., 2010; Prescot et al., 2011;
Prescot et al., 2013; Murray et al., 2016) (also reviewed by Meyerhoff et al., 2013). These studies indicate that alcohol
and illicit substances alter regional neuronal integrity, energy metabolism, membrane synthesis/turnover, the metabolic
pools of Glu and gamma-aminobutyric acid (GABA) that are in equilibrium with their neurotransmitter pools, and gliotic/
inflammatory processes (Yang et al., 2009; Licata and Renshaw, 2010). In several of the MRS reports cited here, the brain
metabolite abnormalities correlated with the duration of substance use and neurocognitive deficits (e.g., Murray et al.,
2016).
Furthermore, chronic cigarette smoking compounds and regional brain metabolite abnormalities (and neurocognitive
dysfunction, see above) are observed in AUD (Meyerhoff, 2007; Wang et al., 2009; Durazzo et al., 2013). The chronic
abuse of different substances is associated with tissue alterations in largely similar brain regions, primarily in the prefrontal
cortex (PFC), the underlying white matter, the thalami, and the basal ganglia including striatal structures (Holman et al.,
1991; Volkow et al., 1992; Weber et al., 1993; Ernst et al., 2000a,b; Sullivan, 2000; Sullivan et al., 2000; Franklin et
al., 2002; Matochik et al., 2003; Eldreth et al., 2004; Thompson et al., 2004; Dom et al., 2005; Matochik et al., 2005;
Nordahl et al., 2005; Bae et al., 2006; Hermann et al., 2007; Sorg et al., 2012; Wang et al., 2015; Murray et al., 2016).
Specifically, the dorsolateral PFC is implicated in executive functions involving planning and organization, response
inhibition, working memory, reasoning, problem solving, set shifting, and goal-directed behavior (e.g., Goldstein and
Volkow, 2011). The collective subregions of the anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC) combine
to subserve processing of affective or emotional stimuli or contexts, conflict monitoring, interoceptive-autonomic and
reward-processing aspects of reward processing, switching between habitual (overlearned) and goal-directed behavior
based on consequences of actions, and reward identification and acquisition (Volkow and Baler, 2014; Williams, 2016;
Moorman, 2018). As such, the affected brain regions are all critically important for the initiation and maintenance of
addictive behaviors (Volkow et al. 2012, 2013; Volkow and Baler, 2014).
We have also studied the neurobiological consequences of polysubstance use via brain MRS. Early studies suggested
that alcohol-dependent individuals with and without cocaine dependence differed in their regional metabolite
concentrations and the brain regions primarily affected (Meyerhoff et al., 1999). More recent studies compared
1-month-abstinent PSU to drug-free controls and found lower NAA, Cr, and mI in the dorsolateral PFC of PSU, with
lower prefrontal NAA in PSU related to poorer visuospatial learning/memory and working memory (Abé et al., 2013).
While prefrontal Glu levels were normal in these PSU, GABA tended to be reduced in the ACC, and lower GABA in
the dorsolateral PFC was associated with greater cocaine consumption. In contrast, dorsolateral PFC metabolite levels and
prefrontal GABA levels were normal in age-equivalent AUD with similar lifetime drinking histories, and initially low
NAA, Cr, and mI levels in the ACC of these AUD had all normalized by 1 month of abstinence from alcohol (Mon et al.,
2012). As such, metabolite alterations appear to be regionally different in abstinent PSU and AUD, more pronounced in the
dorsolateral PFC of PSU, which may signal more enduring brain injury during abstinence in PSU. The detected metabolite
abnormalities in PSU were unrelated to age, alcohol consumption, body mass index, smoking status, as well as comorbid
depression and anxiety symptomatologies; the abnormalities were likely related to the misuse of illicit drugs in PSU. Such
cross-sectional comparisons of brain alterations across different substance-using groups suggest slightly different brain
injuries and recovery dynamics that suggest better targeted approaches for optimal treatment.
Neurobiological changes during abstinence
The cross-sectional neuroimaging abnormalities described above were reported to either relate or not relate to abstinence
duration (e.g., Hanlon et al., 2013; Yucel et al., 2016); thus, they could be a consequence of alcohol/substance abuse
and the associated lifestyle, a premorbid risk factor for its development, or both. Only serial studies focusing on
neurobiological recovery during sustained abstinence can distinguish between these interpretations by providing evidence
Modeling neurocognitive and neurobiological recovery in addiction
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of recovery from brain abnormalities during abstinence. Poor subject retention, however (Morales et al., 2012; Salo and
Fassbender, 2012; Hanlon et al., 2013; Mackey and Paulus, 2013), has limited the execution of longitudinal neuroimaging
studies in treatment seekers during abstinence, especially in illicit substance abusers.
The best evidence for beneficial neuroadaptation during sobriety is available from longitudinal morphometric
neuroimaging studies of treatment seekers abstinent from alcohol (see reviews by Buhler and Mann, 2011; Meyerhoff,
2014; Zahr, 2014; Durazzo et al., 2015a,b; Charlet et al., 2018). Brain volume increases can be demonstrated by
quantitative MRI within as few as 14 days of abstinence (van Eijk et al., 2013; Durazzo et al., 2015a,b; Zou et al., 2018),
driven by increases in regional frontal, occipital, and parietal cortical thickness but not surface area (Wang et al., 2016);
reduced subcortical volumes did not recover over the first 2 weeks of abstinence (van Eijk et al., 2013). Volume increases
were also observed over a 6-month follow-up period in a few select brain regions (including cerebellar vermis and
cingulate gyrus) in those who did not manage to achieve complete abstinence (i.e., those who engaged in some low-level
drinking after treatment with no resumption of heavy consumption) (Segobin et al., 2014), supporting the harm reduction
theory in AUD treatment. Hippocampal volume recovery within the first month of alcohol abstinence was a function of
brain-derived neurotrophic factor genotype (Hoefer et al., 2014) and associated with improvements in visual short- and
long-term memory (Gazdzinski et al., 2008). When investigated, repeat studies in abstinent individuals often indicate
positive associations between volumetric and neurocognitive recoveries (Durazzo and Meyerhoff, 2007; Meyerhoff, 2008).
Almost all longitudinal neuroimaging studies in addiction involved one follow-up examination after a few weeks
of abstinence; only a few studies used at least three assessment points (Pfefferbaum et al., 1995; Agartz et al., 2003;
Gazdzinski et al., 2005a,b; Yeh et al., 2007; Hoefer et al., 2014; Durazzo et al., 2015a,b; Zou et al., 2018) to investigate
the trajectory of brain volume recovery over a longer period of abstinence from alcohol. In an early study of the temporal
dynamics of volume recovery (Gazdzinski et al., 2005a,b), we observed that approximately 50% of the tissue volume
recovery of the entire brain over 7–12 months of continuous abstinence occurred during the first month of abstinence. We
also showed that a nonlinear mathematical formula predicted very well the experimentally observed data for lobar gray and
white matter volume changes (Mon et al., 2011). Further analyses of structural imaging data from a similar cohort (Durazzo
et al., 2015a,b) revealed that gray matter volumes increased significantly in the frontal, parietal, and occipital lobes of
AUD between 1 week and 7.5 months of abstinence. However, the monthly gray matter volume change rates of the frontal
and parietal lobes were significantly greater between 1 week and 1 month of abstinence than between 1 and 7.5 months
of abstinence, suggesting a nonlinear gray matter volume recovery trajectory with faster recovery in earlier phases of
sobriety. In a follow-up study, we observed that the functionally distinct dorsolateral PFC, OFC, and insula had nonlinear
volume recovery trajectories over long-term abstinence, whereas the trajectories for the ACC and hippocampus were linear
over the entire observation period (Zou et al., 2018). This gray matter plasticity apparent during alcohol abstinence and its
timing may have important treatment implications. Specifically, the degree of regional structural recovery during early and
later phases of abstinence may identify those at increased risk for relapse and inform the type and timing of interventions
that promote the most efficient adaptive neuroplasticity during early recovery (Seo and Sinha, 2015; Seo et al., 2015;
Durazzo and Meyerhoff, 2017).
Methamphetamine-dependent individuals showed volume increases in inferior frontal, angular, and superior temporal
gyri, precuneus, insula, and occipital pole over 4 weeks of abstinence (Morales et al., 2012). In cocaine-dependent
treatment seekers, PFC volume recovered between months 5 and 9 of abstinence; increases in inferior frontal gyrus as
well as ventromedial PFC volumes were associated with improvements in cognitive flexibility and decision-making,
respectively (Parvaz et al., 2017). In this study, lapses did not necessarily impede cortical volume recovery. Similarly,
reducing (not ceasing) cocaine use in heavy users over 19 months was associated with thickening of the lateral frontal
cortices that related to better attention (Hirsiger et al., 2019). These latter studies lend initial support for a harm reduction
model also in cocaine use disorder treatment.
In unpublished neuroimaging studies of 20 PSU patients between 1 and 4 months of abstinence (a subgroup of
individuals described in the cross-sectional PSU neuroimaging analyses above) (Pennington et al., 2015), we found
evidence for widespread volumetric change also in individuals who co-abused alcohol and stimulants for more than 20
years: an increase in left caudate volume, a decrease in right superior temporal lobe volume, and trends to decreasing
insula and entorhinal cortex volumes (unpublished). These changes, however, were much less dramatic than observed in
short-term abstinent AUD described above. Given that abnormalities in PSU involved both smaller and larger regional
tissue volumes (purportedly from competing neural mechanisms—see cross-sectional review above), observing both
volume increases and decreases across different brain regions during sustained abstinence is not surprising and may relate
to the competing morphometric processes and altered functional connectivity postulated among these brain regions.
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Longitudinal MRS studies have been used to try to further understand the tissue changes that underlie volume
changes during recovery. We showed in a series of studies in recovering AUD that after correcting for parallel tissue
volume changes, NAA and Cho concentrations throughout the brain recovered significantly, but variably over 5 weeks
of abstinence, with some of the metabolite changes related to improvements in specific neurocognitive domains (Durazzo
et al., 2006a, Gazdzinski et al. 2008). The brain metabolite recovery was generally greater in nonsmoking than smoking
AUD (Meyerhoff, 2007), with less frontal white matter NAA recovery related to longer smoking duration (Durazzo
et al., 2006a). In an MRS study of recently abstinent methamphetamine abusers, low Glu in ACC recovered over 5
months of abstinence, together with a reduction of craving (Ernst and Chang, 2008). Over just 4 weeks of abstinence,
however, prefrontal NAA and Cho in intravenous methamphetamine users did not change significantly (Yoon et al.,
2010), in contrast to observations in short-term abstinent AUD. In our small cohort of abstinent PSU, regional metabolite
concentrations recovered between 1 and 3 months of abstinence to levels commensurate with controls (unpublished).
Specifically, NAA and Cho in the dorsolateral PFC and GABA and NAA in the ACC significantly increased, while Glu
and mI in the ACC and mI in the parieto-occipital gray matter decreased; the NAA increases in ACC and dorsolateral PFC
correlated with improvements in visuospatial learning and working memory, respectively.
The observed brain tissue volume and metabolite level changes during abstinence from alcohol and/or substances may
partially reflect the reversal of maladaptive neuroplastic processes associated with chronic long-term alcohol/substance
abuse (Koob, 2009). While initial significant neurobiological changes have been observed within the first month of
abstinence in AUD, fewer studies describe such early processes in illicit substance users, reminiscent of the dynamics
of potentially related neurocognitive improvements (see above). Neurobiological improvements are observable over
many months, even years after initiation of abstinence. They are likely not the result of a single neural process but of
several different processes involving different cell types and populations to various degrees—sometimes potentially with
opposing effects on regional MR-based outcome measures and with various temporal dynamics. Given the demonstrated
associations between neurobiological and neurocognitive measures, this may give rise to the relatively large variability
observed for neurocognitive recovery across different substance-using groups and among individuals in the same
substance-using group during abstinence. Data from humans and animal models suggest the tissue volume recovery
in AUD during early and extended abstinence is related to increases in neuronal dendritic arbor, soma/cell volume,
synaptic density, nonreactive glial proliferation (particularly microglia), and remyelination (e.g., Dlugos and Pentney,
1997; Sullivan and Pfefferbaum, 2005; Crews and Nixon, 2009; Anderson, 2011; Zatorre et al., 2012), which are all
intrinsic neuroadaptations that are also instrumental in experience-based learning and memory (Anderson, 2011; Zatorre et
al., 2012). The metabolite concentration changes that often accompany morphometric changes during abstinence may also
be related to these mechanisms.
Clinically relevant modulators of the degree of regional volume reduction in adult AUD and of the extent of structural
recovery during abstinence have been identified; they include age, gender, family history of problem drinking and genetic
factors, degree of baseline atrophy, number of detoxifications, and comorbid medical (hepatitis C and hypertension),
psychiatric (depression, anxiety), and SUDs including tobacco use disorder (Duka et al., 2003; Cardenas et al. 2005,
2007; Gazdzinski et al., 2005a,b; Durazzo et al., 2007a,b; Demirakca et al., 2011; Mon et al., 2013; Hoefer et al., 2014;
Pennington et al., 2015; Durazzo and Meyerhoff, 2017; Sullivan et al., 2018). The same factors as well as stress and
stress response (Blaine and Sinha, 2017) also modulate metabolic and functional brain injury and recovery in AUD.
Finally, a critical determinant of brain injury is the age of onset of substance use, with substance-associated brain changes
in adolescents being different both qualitatively and quantitatively from those in adults, as they likely interact with
brain development. Studying the effects of substance use cessation in the developing brain is in its infancy, with the
current Adolescent Brain Cognitive Development (ABCD) Study, a longitudinal, observational study of over 10,000 youth
recruited throughout the United States, promising to address this issue.
CONCLUSIONS AND OUTLOOK
Given these many modulators of neurobiology in alcohol and SUDs, some of which are also risk factors for relapse
(Durazzo et al., 2010b; Rando et al., 2011; Seo and Sinha, 2015; Seo et al., 2015; Durazzo and Meyerhoff, 2017),
neurobiological and neurocognitive recovery with abstinence from alcohol and other substances is complex and not
trivial to study and interpret in a meaningful way. Even more challenging will be to incorporate some of these research
findings into clinical practice. One successful example of such development is the now much more widespread integration
of smoking cessation into substance abuse treatment: tobacco use, a significant but modifiable health risk for both
relapse and common psychiatric comorbidities in AUD, has a greater annual mortality than SUD and AUD
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combined, and we can ill afford to continue ignoring it in addiction treatment (Weinberger et al., 2015). It has been
demonstrated that treating tobacco use effectively in those seeking treatment for their (other) substance abuse may promote
better long-term outcomes (Kalman et al., 2010; Cavazos-Rehg et al., 2014; Durazzo and Meyerhoff, 2017). But our
efforts cannot end here, as newer forms of nicotine delivery (e.g., vaping/e-cigarettes) also need to be considered carefully
regarding their addictive and brain-altering potentials.
Despite the seemingly overwhelming complexities in studying brain function, morphometry, and recovery in human
addiction, demonstrating specific neuroadaptations after detoxification, their time courses, and their dependence on critical
modulators are important for several reasons: (1) There might be an optimal window of opportunity for augmenting such
intrinsic neurobiological repair processes (neuroplasticity) via interventions such as plasticity-based cognitive remediation,
magnetic/electrical stimulation, or pharmacotherapy; (2) many neurocognitive deficits and/or their neurobiological
correlates are not premorbid/risk factors of abuse, but rather consequences of abuse, and brain function and tissue
integrity can improve with sustained abstinence; and (3) relapse risk likely decreases over time with abstinence as
brain neurobiology and functions recover from injury (adaptive neuroplasticity). Identifying the specific neurobiological
mechanisms associated with such improvements, their mitigating factors, time courses, and trajectories can critically
inform interventions aimed at facilitating brain repair and recovery processes, such as strengthening prefrontal neural
connectivity or employing GABAergic therapy to improve inhibitory control. A recent opinion piece (Humphreys
and Bickel, 2018) calls for “expanding and deepening the neuroscience of recovery from addiction” to improve
addiction-focused clinical care and public policy. In that spirit, we hope that this chapter contributes to describing a critical
part of the current state of addiction recovery research.
Finally, it is noteworthy that all recovery research described in this chapter has been conducted in individuals having
(ostensibly) achieved complete abstinence from alcohol and other substances. Research has rarely examined psychological
or physical functioning in moderation-focused treatment approaches (see, e.g., Witkiewitz et al., 2019). Given the
increasing consideration of treatment outcome endpoints other than complete abstinence, future research will almost
certainly be conducted to better understand the degree of neurobiological recovery associated with reduced substance
use (harm reduction from nonabstinence-based recovery). Additional research might focus on recovery processes that go
beyond the standard treatment durations of several months described here, to better understand neuropsychological and
neurobiological factors associated with sustained recovery in later years when treated individuals remain at some degree
of relapse risk.
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